Meredith Larson, MD
Family Medicine · Carmel, INNPI 1992169700
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $167 and has fallen 69.7% since, to $51 in 2022. That places this record below the midpoint for family medicine clinicians in IN, where the typical reported total is $501.
Across 26 payments — averaging $15.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$62
- Novo Nordisk$55
- Lilly USA, LLC$55
- Merck$50
- AstraZeneca$46
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$30
- plus $94 from 5 others
What the payments were for
- Food & beverage$393100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 4 | $62 |
| Novo Nordisk | 3 | $55 |
| Lilly USA, LLC | 4 | $55 |
| Merck | 3 | $50 |
| AstraZeneca(2 entities) | 3 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Boehringer Ingelheim | 2 | $24 |
| Pfizer | 2 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $15 |
| GSK | 1 | $15 |
How this compares
$393 in reported general payments places this provider in the 45th percentile of 2,709 family medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 11 | $1,070 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $385 |
| Gabapentin | 16 | $363 |
| Omeprazole | 20 | $328 |
| Amlodipine Besylate | 35 | $238 |
| Atorvastatin Calcium | 27 | $236 |
| Zolpidem Tartrate | 15 | $164 |
| Rosuvastatin Calcium | 21 | $158 |
| Metoprolol Succinate | 19 | $143 |
| Lisinopril | 37 | $128 |
| Losartan Potassium | 19 | $125 |
| Hydrochlorothiazide | 13 | $97 |
| Sertraline Hcl | 20 | $85 |
| Tamsulosin Hcl | 12 | $68 |
| Levothyroxine Sodium | 17 | $56 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Carmel
- Shekar PushpalaCarmel$239K
- Richard TannerIndianapolis$1.6M
- James AndryBloomington$715K
- Richard FeldmanIndianapolis$476K
- Anthony InzerelloEvansville$308K
- Joe BanksIndianapolis$294K
- Steven GatewoodElwood$281K
- Victoria MoyerKokomo$188K
- Thomas KintanarFort Wayne$185K
- Jeffrey HiltzMuncie$177K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.